Business ❯Investing ❯Venture Capital
Company Valuation Technology Startups Artificial Intelligence Investor Relations Research and Development Physical Intelligence Uber Eric Schmidt OpenAI Valuation Waabi
Pending Hart-Scott-Rodino approval, AbbVie will integrate Capstan’s Phase 1 CAR-T candidate with its targeted lipid nanoparticle platform for precise RNA delivery.